Effect of Dapagliflozin on Atrial Fibrillation in Patients with Type 2 Diabetes Mellitus: Insights from the DECLARE-TIMI 58 Trial

Citation
Zelniker TA, Bonaca MP, Furtado RHM, et al. Circulation 2020;141:1227–34.